By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company SanBio Company Limited

SanBio Company Limited (SNBIF)

OTC Market Data in USD, Fundamentals in JPY
$16.45
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$1.18B
Market Cap
-76.53
P/E Ratio (TTM)
Forward Dividend Yield
$3.85 - $16.45
52 Week Range

SNBIF Stock Price Chart

Explore SanBio Company Limited interactive price chart. Choose custom timeframes to analyze SNBIF price movements and trends.

SNBIF Company Profile

Discover essential business fundamentals and corporate details for SanBio Company Limited (SNBIF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

12 Oct 2015

Employees

29.00

CEO

Keita Mori MBA

Description

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, spinal cord injury, Parkinson's disease, Alzheimer's disease, and others; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.

SNBIF Financial Timeline

Browse a chronological timeline of SanBio Company Limited corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 16 Mar 2026

Upcoming earnings on 15 Dec 2025

Upcoming earnings on 15 Sept 2025

Earnings released on 13 Jun 2025

EPS came in at -$0.15 .

Earnings released on 17 Mar 2025

EPS came in at -$0.07 .

Earnings released on 16 Dec 2024

EPS came in at -$0.08 surpassing the estimated -$0.12 by +33.21%.

Earnings released on 17 Sept 2024

EPS came in at -$0.12 surpassing the estimated -$0.12 by +5.60%.

Earnings released on 13 Jun 2024

EPS came in at -$0.01 surpassing the estimated -$0.12 by +88.21%.

Earnings released on 18 Mar 2024

EPS came in at -$0.08 .

Earnings released on 31 Oct 2023

EPS came in at -$0.01 .

Earnings released on 31 Jul 2023

EPS came in at -$0.13 .

Earnings released on 30 Apr 2023

EPS came in at -$0.07 .

Earnings released on 16 Mar 2023

EPS came in at -$61.10 .

Earnings released on 15 Dec 2022

EPS came in at $6.65 .

Earnings released on 14 Sept 2022

EPS came in at -$32.28 .

Earnings released on 14 Jun 2022

EPS came in at -$5.98 .

Earnings released on 11 Mar 2022

EPS came in at -$30.17 .

Earnings released on 15 Dec 2021

EPS came in at -$18.95 .

Earnings released on 14 Sept 2021

EPS came in at -$24.60 .

Earnings released on 14 Jun 2021

EPS came in at -$16.61 .

Earnings released on 17 Mar 2021

EPS came in at $28.11 .

Earnings released on 15 Dec 2020

EPS came in at -$31.56 .

Earnings released on 14 Sept 2020

EPS came in at -$32.83 .

SNBIF Stock Performance

Access detailed SNBIF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run